Dianthus Therapeutics
DNTH
DNTH
95 hedge funds and large institutions have $248M invested in Dianthus Therapeutics in 2020 Q2 according to their latest regulatory filings, with 26 funds opening new positions, 31 increasing their positions, 23 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
0.02% less ownership
Funds ownership: 4.41% → 4.39% (-0.02%)
97% less call options, than puts
Call options by funds: $4K | Put options by funds: $117K
Holders
95
Holding in Top 10
2
Calls
$4K
Puts
$117K
Top Buyers
| 1 | +$4.51M | |
| 2 | +$4.28M | |
| 3 | +$3.38M | |
| 4 |
EC
EcoR1 Capital
San Francisco,
California
|
+$3.38M |
| 5 |
CH
CVI Holdings
Wilmington,
Delaware
|
+$3.11M |
Top Sellers
| 1 | -$2.88M | |
| 2 | -$495K | |
| 3 | -$371K | |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
-$305K |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$171K |